Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults (Q36172965)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
scientific article

    Statements

    Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults (English)
    0 references
    0 references
    0 references
    Ouzama Nicholson
    Fay Dicandilo
    Xiao Sun
    Erin Quirk
    Michelle Miller
    Michael N Robertson
    Devan V Mehrotra
    Katherine Turner
    Jorge Sanchez
    Punnee Pitisuttithum
    Sheri Dubey
    Lisa Kierstead
    Danilo Casimiro
    for the Merck V520-018/HIV Vaccine Trials Network 050 Study Team
    23 November 2010
    27
    0 references
    5
    0 references
    557-567
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit